Cargando…
The current status of gene therapy for Parkinson's disease
The recent development of viral vectors, especially vectors derived from adeno–associated virus (AAV), has translated gene therapy for Parkinson's disease (PD) from animal experiments into clinical trials. The current gene therapy protocols used are based on three major strategies. The first pr...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Indian Academy of Neurosciences
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116997/ https://www.ncbi.nlm.nih.gov/pubmed/25205879 http://dx.doi.org/10.5214/ans.0972-7531.1017209 |